European Indexes Close Mixed

Continental indexes were flat Monday morning despite a wide variety of corporate news

From Standard & Poor's European MarketScope

European indexes closed mixed Monday. Oil stocks were lower as OPEC highlighted signs of a weaker market next year: BP (BP) (-0.78%), Royal Dutch Shell (RDS)(-0.93%). A flat to higher start on Wall Street did little to boost sentiment. The third quarter US current account deficit widened in line with expectations, to US$225.6 billion.

UK: The FTSE index ended slightly lower, with 6-4 negative breadth and very mixed newsflow. Smith & Nephew's early gains turned to a 8.2% rally thanks to an upgrade from Merrill Lynch. The shares also cheered news that the group had ended takeover talks with Biomet.

At the other extreme was Tate & Lyle (-5.5%) after saying that margins from ethanol will be substantially lower and sugar prices are unlikely to rise next year. BT (BT) (-1.3%) was the wrong call today after announcing that its pension deficit has been valued at £3.4 billion as at end-2005. Peer C&W (-0.6%) was also down on news that it is facing £22 million lawsuits in the Caribbean.

Unilever (UN) (+0.25%) cheered reports that Ericsson's Michael Treschow will be the new chairman. India's Tata is seen sticking with its offer for Corus (CGA) (-0.6%), according to the Daily Mail. National Express (+3.0%) said it is ending fiscal 2006 on a strong footing. BAE Systems (-1.4%) will enter the race for Devonport, according to the Sunday Telegraph.

France: The CAC 40 index (-0.2%) ended Monday's session a touch below the gain line with Total (TOT) (-1.26%) weighing amid a falling oil price. Schneider (+1.21%) outperformed as it signed a joint venture agreement in China with Delixi Group. Cap Gemini (+0.62%) has won a seven-year contract with Tetra Pak. Danone (DA) (-0.42%) will form a joint venture to make and sell yoghurt products in China with the country's largest producer of liquid milk, China Mengniu Dairy. Danone will hold 49% of the venture.

On the downside, FDA advisers urged Sanofi (SNY) (-0.57%) to stop selling Ketek to treat bronchitis and sinusitis in the US due to liver damage. France Telecom (FTE) (-0.19%) denied talks with Google (GOOG) about hosting Google's services on its mobile phones.

Germany wants a broader shareholder base at EADS (-0.29%). A number of banks are understood to have been asked in recent days if they would consider joining a consortium to buy part of the stake in the group held by Germany's DaimlerChrysler (DCX). Elsewhere, Areva (-0.44%) was marked lower as China picked Toshiba for a US$5.3 billion nuclear reactor contract. Vallourec (-0.41%) may make acquisitions, and is large enough to develop on a stand-alone basis, according to an interview with CEO Verluca in Le Journal des Finances.

Germany: The Xetra-Dax index (+0.13%) closed in the black. In local news, MAN (-0.27%) won a ruling to claim at least US$488 million from DaimlerChrysler (DCX) (+0.09%). Audi will achieve a return on investment of above 10% this year for the first time, Automobilwoche reported, citing information from VW (+1.70%). This compares to 9.7% last year. Consulting teams are to be sent to Porsche's (+0.83%) German and Spanish plants to undertake efficiency gains analysis.

Key for Deutsche Telekom (DT) (-0.86%): the No. 2 mobile phone services provider in Germany, Vodafone (VOD), reportedly won some 800,000 new subscribers in recent weeks. BASF (BF) (-0.01%) acquired Chinese chemicals company Hi Con Concrete Admixture for an undisclosed sum.

Fresenius AG's (FMS) (+2.75%) trifunctional antibody Removab showed encouraging results in malignant ascites in patients with ovarian cancer. Rhoen Klinikum (+1.42%) upped its 2006 earnings forecast as a result of one-off tax effect, to €106 million from €93 million.

Elsewhere: The Nordic bourses finished flat to higher, with Oslo rallying as M&A activity in the oil sector provided a massive boost to the index. The Spanish Ibex 35 index ended Monday's session lower with BBVA and Repsol (REP) responsible for the biggest points declines.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE